Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Vera Frajzyngier"'
Autor:
Maral, DerSarkissian, Yinong, Young-Xu, Mei Sheng, Duh, Rachel H, Bhak, Niki, Palmetto, Eric, Mortensen, Antonio, Anzueto, Catherine, Nguyen, Mu, Cheng, Vera, Frajzyngier, Suna, Park, Angela, Lax, Lisa B, Weatherby, Alexander M, Walker
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:840-850
Azithromycin is a common first-line antibiotic for respiratory infection; however, there is conflicting evidence regarding risk of cardiovascular death. We assessed cardiovascular and noncardiovascular mortality associated with azithromycin versus am
Autor:
Vera Frajzyngier, Scott T. Rottinghaus, Alvaro Quintana, Anne Hickman, Matteo Bassetti, Philippe Montravers, Michele Wible, Nathalie Baillon-Plot, Christian Eckmann, Hal Tucker, Rebecca Lundin
Publikováno v:
Pharmaceutical Medicine. 31:89-99
Risk minimization measures (RMM) were implemented from February 2011 in the European Union to address risks of superinfection, off-label use and lack of efficacy associated with tigecycline. The objective of this study was to evaluate RMM effectivene
Autor:
Alexandre Delamou, Evelyn Landry, Tagie Gbawuru-Mansaray, Steven D. Arrowsmith, Karen Beattie, Ileogben Sunday-Adeoye, Mulu Muleta, Dantani Danladi, Lilian Were, Sihem Landoulsi, Thierno Hamidou Barry, A Metin Gülmezoglu, Mariana Widmer, Robert Olupot, Alyona Lewis, Vera Frajzyngier, Weston Khisa Wakasiaka, Lucien Djangnikpo, Dolores Nembunzu, Mark A. Barone, Joseph Ruminjo, Issoufa Harou, Armando Seuc
Publikováno v:
The Lancet. 386:56-62
Summary Background Duration of bladder catheterisation after female genital fistula repair varies widely. We aimed to establish whether 7 day bladder catheterisation was non-inferior to 14 days in terms of incidence of fistula repair breakdown in wom
Safety signal detection and evaluation in clinical development programs: A case study of tofacitinib
Publikováno v:
Pharmacology Research & Perspectives
Adverse events are anticipated during a clinical development program. Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We describe here the process undertaken by Pfizer to investigate a safety signal for p
Publikováno v:
Global Health, Science and Practice
Trained, experienced nurses and clinical officers provided safe voluntary medical male circumcision (VMMC) in public health facilities in Nyanza Province, Kenya, as evidenced by the low 2% adverse event rate (most commonly, excess swelling). Task shi
Autor:
Vera Frajzyngier, Abubakar Bello, Dantani Danladi, Joseph Ruminjo, Dulal Chandra Podder, Thierno Hamidou Barry, Maman Inoussa, Felicity Mussell, Saʼad Idris, Sanda Oumarou Ganda, Frank Asiimwe, Maura Lynch, Mark A. Barone
Publikováno v:
Obstetrics & Gynecology. 120:524-531
It is estimated that up to 2 million women in resource poor countries are living with a urinary or recto-vaginal fistula (1,2), primarily as a result of prolonged obstructed labor.(3) Despite the growing number of studies examining factors influencin
Autor:
DC Podder, Vera Frajzyngier, D Danladi, F Mussell, Maura Lynch, M Inoussa, A Bello, TH Barry, SO Ganda, Mark A. Barone, F Asiimwe, Joseph Ruminjo, S Idris
Publikováno v:
Bjog
Please cite this paper as: Frajzyngier V, Ruminjo J, Asiimwe F, Barry T, Bello A, Danladi D, Ganda S, Idris S, Inoussa M, Lynch M, Mussell F, Podder D, Barone M. Factors influencing choice of surgical route of repair of genitourinary fistula, and the
Publikováno v:
Drug and Alcohol Dependence. 89:145-152
Objectives To examine gender differences in drug injection equipment sharing at injecting initiation. Methods Young injecting drug users (IDUs) in New York City February 1999–2003 were surveyed about injection risk behaviors and circumstances at in
Autor:
Abba Wali, Frank Asiimwe, Erin Mielke, Abubakar Bello, Bashir Kanoma, Vera Frajzyngier, Joseph Ruminjo, Dantani Danladi, Dulal Chandra Podder, Maura Lynch, Thierno Hamidou Barry, Maman Inoussa, Evelyn Landry, Mark A. Barone, Sa’ad Idris, Sanda Oumarou Ganda, Felicity Mussell
Publikováno v:
Global Public Health
This article presents data from 1354 women from five countries who participated in a prospective cohort study conducted between 2007 and 2010. Women undergoing surgery for fistula repair were interviewed at the time of admission, discharge, and at a
Autor:
Vera Frajzyngier, A Metin Gülmezoglu, Dolores Nembunzu, Mark A. Barone, Thierno Hamidou Barry, Evelyn Landry, Mulu Muleta, Armando Seuc, Steven D. Arrowsmith, Alyona Lewis, Joseph Ruminjo, Robert Olupot, Karen Beattie, Ileogben Sunday-Adeoye, Mariana Widmer, Weston Khisa Wakasiaka
Publikováno v:
BMC Women's Health, Vol 12, Iss 1, p 5 (2012)
BMC Women's Health
BMC Women's Health
Background A vaginal fistula is a devastating condition, affecting an estimated 2 million girls and women across Africa and Asia. There are numerous challenges associated with providing fistula repair services in developing countries, including limit